BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 27649026)

  • 41. Advances in neuro-oncology imaging.
    Langen KJ; Galldiks N; Hattingen E; Shah NJ
    Nat Rev Neurol; 2017 May; 13(5):279-289. PubMed ID: 28387340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
    Kim JY; Gatenby RA
    Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response.
    Verduin M; Compter I; Steijvers D; Postma AA; Eekers DBP; Anten MM; Ackermans L; Ter Laan M; Leijenaar RTH; van de Weijer T; Tjan-Heijnen VCG; Hoeben A; Vooijs M
    Dis Markers; 2018; 2018():2908609. PubMed ID: 29581794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proton MRS imaging in pediatric brain tumors.
    Zarifi M; Tzika AA
    Pediatr Radiol; 2016 Jun; 46(7):952-62. PubMed ID: 27233788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymphomas-Part 1.
    Brandão LA; Castillo M
    Neuroimaging Clin N Am; 2016 Nov; 26(4):511-536. PubMed ID: 27712792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imaging of Brain Tumors.
    Jordan JT; Gerstner ER
    Continuum (Minneap Minn); 2023 Feb; 29(1):171-193. PubMed ID: 36795877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Computational Fractal-Based Analysis of MR Susceptibility-Weighted Imaging (SWI) in Neuro-Oncology and Neurotraumatology.
    Di Ieva A
    Adv Neurobiol; 2024; 36():445-468. PubMed ID: 38468047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imaging Correlates of Adult Glioma Genotypes.
    Smits M; van den Bent MJ
    Radiology; 2017 Aug; 284(2):316-331. PubMed ID: 28723281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroimaging.
    Pope WB; Djoukhadar I; Jackson A
    Handb Clin Neurol; 2016; 134():27-50. PubMed ID: 26948347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 7-T Magnetic Resonance Imaging in the Management of Brain Tumors.
    Morrison MA; Lupo JM
    Magn Reson Imaging Clin N Am; 2021 Feb; 29(1):83-102. PubMed ID: 33237018
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Imaging brain tumour microstructure.
    Nilsson M; Englund E; Szczepankiewicz F; van Westen D; Sundgren PC
    Neuroimage; 2018 Nov; 182():232-250. PubMed ID: 29751058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Computer-based magnetic resonance imaging as a tool in clinical diagnosis in neurodegenerative diseases.
    Kassubek J; Müller HP
    Expert Rev Neurother; 2016; 16(3):295-306. PubMed ID: 26807776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications.
    Jain R
    NMR Biomed; 2013 Aug; 26(8):1042-9. PubMed ID: 23832526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emerging Applications of Artificial Intelligence in Neuro-Oncology.
    Rudie JD; Rauschecker AM; Bryan RN; Davatzikos C; Mohan S
    Radiology; 2019 Mar; 290(3):607-618. PubMed ID: 30667332
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging.
    Tietze A; Boldsen JK; Mouridsen K; Ribe L; Dyve S; Cortnum S; Østergaard L; Borghammer P
    Acta Radiol; 2015 Sep; 56(9):1135-44. PubMed ID: 25270372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroimaging: diagnosis and response assessment in glioblastoma.
    Clarke JL; Chang SM
    Cancer J; 2012; 18(1):26-31. PubMed ID: 22290254
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging.
    Fink JR; Muzi M; Peck M; Krohn KA
    J Nucl Med; 2015 Oct; 56(10):1554-61. PubMed ID: 26294301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differentiating Between Primary Central Nervous System Lymphomas and Glioblastomas: Combined Use of Perfusion-Weighted and Diffusion-Weighted Magnetic Resonance Imaging.
    Makino K; Hirai T; Nakamura H; Kuroda JI; Shinojima N; Uetani H; Kitajima M; Yano S
    World Neurosurg; 2018 Apr; 112():e1-e6. PubMed ID: 29104150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Imaging signatures of glioblastoma molecular characteristics: A radiogenomics review.
    Fathi Kazerooni A; Bakas S; Saligheh Rad H; Davatzikos C
    J Magn Reson Imaging; 2020 Jul; 52(1):54-69. PubMed ID: 31456318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imaging and treatment of brain tumors through molecular targeting: Recent clinical advances.
    Zaccagna F; Grist JT; Quartuccio N; Riemer F; Fraioli F; Caracò C; Halsey R; Aldalilah Y; Cunningham CH; Massoud TF; Aloj L; Gallagher FA
    Eur J Radiol; 2021 Sep; 142():109842. PubMed ID: 34274843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.